Theravance Biopharma, Inc. - Ordinary Shares (TBPH): Price and Financial Metrics

TBPH POWR Grades

• TBPH scores best on the Growth dimension, with a Growth rank ahead of 92.07% of US stocks.
• TBPH's strongest trending metric is Growth; it's been moving up over the last 179 days.
• TBPH ranks lowest in Sentiment; there it ranks in the 6th percentile.

TBPH Stock Summary

• The capital turnover (annual revenue relative to shareholder's equity) for TBPH is -0.16 -- better than merely 5.22% of US stocks.
• Equity multiplier, or assets relative to shareholders' equity, comes in at -1.18 for Theravance Biopharma Inc; that's greater than it is for only 4.72% of US stocks.
• Revenue growth over the past 12 months for Theravance Biopharma Inc comes in at -23.03%, a number that bests only 6.59% of the US stocks we're tracking.
• Stocks that are quantitatively similar to TBPH, based on their financial statements, market capitalization, and price volatility, are AKTS, EDIT, ACRS, RETA, and FREQ.
• Visit TBPH's SEC page to see the company's official filings. To visit the company's web site, go to www.theravance.com.

TBPH Valuation Summary

• TBPH's price/sales ratio is 9.5; this is 150% higher than that of the median Healthcare stock.
• Over the past 89 months, TBPH's price/sales ratio has gone down 3267.9.
• TBPH's EV/EBIT ratio has moved down 0 over the prior 89 months.

Below are key valuation metrics over time for TBPH.

TBPH Growth Metrics

The 2 year net cashflow from operations growth rate now stands at -109.59%.
• Its 5 year net income to common stockholders growth rate is now at -35.75%.
• The 5 year net cashflow from operations growth rate now stands at -52.98%.

Over the past 15 months, TBPH's revenue has gone down $27,315,000.

The table below shows TBPH's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	55.311	-207.858	-199.426
2021-09-30	59.095	-230.349	-225.826
2021-06-30	64.158	-261.934	-264.161
2021-03-31	66.252	-265.167	-274.643
2020-12-31	71.857	-250.403	-278.017
2020-09-30	82.626	-249.83	-285.189

TBPH's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• TBPH has a Quality Grade of D, ranking ahead of 23.9% of graded US stocks.
• TBPH's asset turnover comes in at 0.144 -- ranking 228th of 682 Pharmaceutical Products stocks.
• AVTX, SUPN, and PTCT are the stocks whose asset turnover ratios are most correlated with TBPH.

The table below shows TBPH's key quality metrics over time.